First Manhattan’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Hold |
12,100
| – | – | ﹤0.01% | 679 |
|
|
2025
Q1 | $122K | Hold |
12,100
| – | – | ﹤0.01% | 656 |
|
|
2024
Q4 | $143K | Buy |
12,100
+200
| +2% | +$2.37K | ﹤0.01% | 664 |
|
|
2024
Q3 | $137K | Buy |
11,900
+500
| +4% | +$5.77K | ﹤0.01% | 663 |
|
|
2024
Q2 | $120K | Hold |
11,400
| – | – | ﹤0.01% | 646 |
|
|
2024
Q1 | $120K | Buy |
11,400
+400
| +4% | +$4.22K | ﹤0.01% | 739 |
|
|
2023
Q4 | $124K | Hold |
11,000
| – | – | ﹤0.01% | 726 |
|
|
2023
Q3 | $128K | Hold |
11,000
| – | – | ﹤0.01% | 730 |
|
|
2023
Q2 | $111K | Hold |
11,000
| – | – | ﹤0.01% | 749 |
|
|
2023
Q1 | $81.2K | Buy |
+11,000
| New | +$81.2K | ﹤0.01% | 838 |
|